Etoford P 60 mg/325 mg Tablet is a combination medication containing Etoricoxib 60 mg and Paracetamol 325 mg, designed to provide effective relief from pain and inflammation. Etoricoxib is a selective COX-2 inhibitor that works by reducing the production of prostaglandins, substances responsible for pain and inflammation in the body, making it useful in managing conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Paracetamol, also known as acetaminophen, is a widely used analgesic and antipyretic agent that helps alleviate mild to moderate pain and reduce fever by inhibiting the synthesis of prostaglandins in the central nervous system. The combination of these two active ingredients offers a synergistic effect, providing enhanced pain relief while minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Etoford P is typically prescribed for the management of musculoskeletal pain, dental pain, postoperative pain, and other inflammatory conditions. Patients should use this medication under medical supervision, adhering to the recommended dosage to avoid potential side effects such as gastrointestinal discomfort, liver toxicity from paracetamol overdose, or cardiovascular risks linked to Etoricoxib. It is important to inform the healthcare provider of any pre-existing conditions or concurrent medications before starting Etoford P.